SCHEMBL7188720

SCHEMBL7188720

Cc1ccccc1Cn1cccc1C(=O)CC(=O)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC5 P28715 2/20 0.50
FEN1 P39748 2/20 0.50
LMNA P02545 2/20 0.45
MAP3K14 Q99558 1/20 0.45
MAPT P10636 3/20 0.42
PTPN1 P18031 1/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
PTGER3 P43115 2/20 0.41
THRB P10828 1/20 0.41
POLB P06746 1/20 0.41
TP53 P04637 1/20 0.40
EPHX2 P34913 2/20 0.40
GAA P10253 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ATM Q13315 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
KMT2A Q03164 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7195496 0.84 PTPN1 (0.50) ERCC5FEN1LMNAMAP3K14MAPT
SCHEMBL7195321 0.84 HDAC3 (0.47) ERCC5FEN1LMNAMAP3K14PTPN1
SCHEMBL7924311 0.84 LMNA (0.66) ERCC5FEN1LMNAMAP3K14ALDH1A1
SCHEMBL7185737 0.83 LMNA (0.44) ERCC5FEN1LMNAMAP3K14PTPN1
SCHEMBL7186087 0.82 CNR2 (0.45) ERCC5FEN1LMNAMAP3K14MAPT
SCHEMBL7191689 0.81 CNR2 (0.53) ERCC5FEN1LMNAMAP3K14MAPT
SCHEMBL7195627 0.79 PTPN1 (0.44) ERCC5FEN1LMNAMAP3K14PTPN1
SCHEMBL7179955 0.78 FEN1 (0.46) ERCC5FEN1LMNAMAPTPTPN1
SCHEMBL7924220 0.77 FEN1 (0.42) ERCC5FEN1LMNAMAP3K14PTPN1
SCHEMBL7190690 0.77 CNR2 (0.54) ERCC5FEN1PTPN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1083897-A4 HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2003-01-02 EP claimed
US-6306891-B1 INHIBITORS OF HIV INTEGRASE AND INHIBITORS OF HIV REPLICATION. THESE COMPOUNDS ARE USEFUL IN THE PREVENTION OR TREATMENT OF INFECTION BY HIV TREATMENT OF AIDS, EITHER AS COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE SALTS MERCK & CO., INC. 2001-10-23 US claimed
EP-1083897-A1 HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2001-03-21 EP claimed
WO-1999062513-A1 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 1999-12-09 WO claimed
EP-1083897-A4 HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2003-01-02 EP disclosed
US-6306891-B1 INHIBITORS OF HIV INTEGRASE AND INHIBITORS OF HIV REPLICATION. THESE COMPOUNDS ARE USEFUL IN THE PREVENTION OR TREATMENT OF INFECTION BY HIV TREATMENT OF AIDS, EITHER AS COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE SALTS MERCK & CO., INC. 2001-10-23 US disclosed
EP-1083897-A1 HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2001-03-21 EP disclosed
WO-1999062513-A1 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 1999-12-09 WO disclosed